CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents ($51,253 and $48,806 restricted at December 31, 2019 and September 30, 2020, respectively)	$ 152,050	$ 115,752
Accounts receivable, net	769,159	680,569
Short-term investments ($82,772 and $77,073 restricted at December 31, 2019 and September 30, 2020, respectively)	92,686	98,797
Pharmaceutical inventory	37,637	44,962
Other current assets ($36,215 and $49,380 restricted at December 31, 2019 and September 30, 2020, respectively)	95,666	69,687
Current portion of assets held for sale	1,144,032	663,276
Total Current Assets	2,291,230	1,673,043
Property and equipment, net	131,869	131,712
Long-term investments ($2,307 and $3,585 restricted at December 31, 2019 and September 30, 2020, respectively)	5,623	2,864
Deferred income taxes	25,823	1,840
Other long-term assets	67,692	58,905
Goodwill	806,421	806,421
Other intangible assets, net	52,362	81,675
Assets held for sale, less current portion		335,713
Total Assets	3,381,020	3,092,173
Current Liabilities:
Accounts payable	122,020	83,790
Accrued liabilities	235,152	191,854
Medical claims payable	119,922	128,114
Other medical liabilities	123,205	92,915
Current debt, finance lease and deferred financing obligations	4,308	3,491
Current portion of liabilities held for sale	496,272	409,983
Total Current Liabilities	1,100,879	910,147
Long-term debt, finance lease and deferred financing obligations	637,093	679,125
Deferred income taxes		1,971
Tax contingencies	11,724	9,453
Deferred credits and other long-term liabilities	52,172	56,393
Liabilities held for sale, less current portion		37,301
Total Liabilities	1,801,868	1,694,390
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized-10,000 shares at December 31, 2019 and September 30, 2020-Issued and outstanding-none
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2019 and September 30, 2020-Issued and outstanding-54,285 and 24,623 shares at December 31, 2019, respectively, and 55,269 and 25,607 shares at September 30, 2020, respectively	553	543
Other Stockholders' Equity:
Additional paid-in capital	1,455,009	1,386,616
Retained earnings	1,588,196	1,475,207
Accumulated other comprehensive income	121	144
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2019 and September 30, 2020, respectively	(1,464,727)	(1,464,727)
Total Stockholders' Equity	1,579,152	1,397,783
Total Liabilities and Stockholders' Equity	$ 3,381,020	$ 3,092,173